466 related articles for article (PubMed ID: 32951722)
1. Systematic review and meta-analysis of Chinese herbal medicine as adjuvant treatment in advanced non-small cell lung cancer patients.
Wang LC; Chang YY; Lee IC; Kuo HC; Tsai MY
Complement Ther Med; 2020 Aug; 52():102472. PubMed ID: 32951722
[TBL] [Abstract][Full Text] [Related]
2. Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: a systematic review and meta-analysis.
Liu ZL; Zhu WR; Zhou WC; Ying HF; Zheng L; Guo YB; Chen JX; Shen XH
J Integr Med; 2014 Jul; 12(4):346-58. PubMed ID: 25074884
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines.
Xiao Z; Wang C; Zhou M; Hu S; Jiang Y; Huang X; Li N; Feng J; Tang F; Chen X; Ding J; Chen L; Wang Y; Li X
J Ethnopharmacol; 2019 Jan; 228():110-122. PubMed ID: 30243827
[TBL] [Abstract][Full Text] [Related]
4. Cinobufotalin injection combined with chemotherapy for the treatment of advanced NSCLC in China: A PRISMA-compliant meta-analysis of 29 randomized controlled trials.
Zhang F; Yin Y; Xu T
Medicine (Baltimore); 2019 Aug; 98(35):e16969. PubMed ID: 31464940
[TBL] [Abstract][Full Text] [Related]
5. Aidi injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A meta-analysis of 42 RCTs following the PRISMA guidelines.
Wang J; Li G; Yu L; Mo T; Wu Q; Zhou Z
J Ethnopharmacol; 2018 Jul; 221():137-150. PubMed ID: 29655852
[TBL] [Abstract][Full Text] [Related]
6. Can Aidi injection improve overall survival in patients with non-small cell lung cancer? A systematic review and meta-analysis of 25 randomized controlled trials.
Xiao Z; Wang C; Zhou R; Hu S; Yi N; Feng J; Zhou M; Liu S; Chen L; Ding J; Gong Q; Tang F; Li X
Complement Ther Med; 2018 Apr; 37():50-60. PubMed ID: 29609937
[TBL] [Abstract][Full Text] [Related]
7. Chinese Herbal Medicine for Improving Quality of Life Among Nonsmall Cell Lung Cancer Patients: Overview of Systematic Reviews and Network Meta-Analysis.
Wu X; Chung VCH; Lu P; Poon SK; Hui EP; Lau AYL; Balneaves LG; Wong SYS; Wu JCY
Medicine (Baltimore); 2016 Jan; 95(1):e2410. PubMed ID: 26735544
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy and safety of sodium cantharidinate plus chemotherapy in non-small-cell lung cancer: A systematic review and meta-analysis of 38 randomized controlled trials.
Xiao Z; Wang C; Tan Z; Hu S; Chen Y; Zhou M; Feng J; Liu S; Chen L; Ding J; Gong Q; Tang F; Liu H; Li X
J Clin Pharm Ther; 2019 Feb; 44(1):23-38. PubMed ID: 30229971
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of Chinese herbal injections combined with GP regimen chemotherapy for patients with advanced NSCLC: A protocol for systematic review and network meta-analysis.
Li J; Zhu GH; Liu TT; Xu BW; Li J
Medicine (Baltimore); 2020 Jul; 99(28):e21041. PubMed ID: 32664114
[TBL] [Abstract][Full Text] [Related]
10. Kanglaite injection plus platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A meta-analysis of 27 RCTs.
Huang X; Wang J; Lin W; Zhang N; Du J; Long Z; Yang Y; Zheng B; Zhong F; Wu Q; Ma W
Phytomedicine; 2020 Feb; 67():153154. PubMed ID: 31926475
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of traditional Chinese Medicine combined with chemotherapy in patients with non-small cell lung cancer (NSCLC): a meta-analysis of randomized clinical trials.
Yang J; Zhu X; Yuan P; Liu J; Wang B; Wang G
Support Care Cancer; 2020 Aug; 28(8):3571-3579. PubMed ID: 32266566
[TBL] [Abstract][Full Text] [Related]
12. Xiao-ai-ping injection adjunct with platinum-based chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis.
Feng F; Huang J; Wang Z; Zhang J; Han D; Wu Q; He H; Zhou X
BMC Complement Med Ther; 2020 Jan; 20(1):3. PubMed ID: 32020869
[TBL] [Abstract][Full Text] [Related]
13. Aidi injection as adjunctive treatment to gemcitabine-based chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis.
Guo S; Li Y; Su H; Meng M; Xi J; Mo G; Chen X
Pharm Biol; 2021 Dec; 59(1):1260-1275. PubMed ID: 34541998
[TBL] [Abstract][Full Text] [Related]
14. Can Aidi injection restore cellular immunity and improve clinical efficacy in non-small-cell lung cancer patients treated with platinum-based chemotherapy? A meta-analysis of 17 randomized controlled trials following the PRISMA guidelines.
Xiao Z; Wang C; Sun Y; Li N; Li J; Chen L; Yao X; Ding J; Ma H
Medicine (Baltimore); 2016 Nov; 95(44):e5210. PubMed ID: 27858864
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of Shenqi Fuzheng injection combined with platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A protocol for systematic review and meta-analysis of randomized controlled trials.
Chen H; Yao X; Liu Z; Li T; Xu C; Wang J; Sui X; Leung EL; Wu Q
Medicine (Baltimore); 2019 Sep; 98(39):e17350. PubMed ID: 31574877
[TBL] [Abstract][Full Text] [Related]
16. [Meta-analysis on effectiveness and safety of traditional Chinese medicine combined with first-generation EGFR-TKI in treating advanced non-small cell lung cancer].
He W; Cheng M
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2591-2598. PubMed ID: 28840704
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of Kanglaite plus EGFR-TKI in the treatment of advanced non-small cell lung cancer: A meta-analysis of 13 RCTs.
Li D; Li W; Xu L; Che Y; Cheng C
Medicine (Baltimore); 2022 Dec; 101(50):e32169. PubMed ID: 36550917
[TBL] [Abstract][Full Text] [Related]
18. Effect of gefitinib plus Chinese herbal medicine (CHM) in patients with advanced non-small-cell lung cancer: a retrospective case-control study.
Yang XB; Wu WY; Long SQ; Deng H; Pan ZQ
Complement Ther Med; 2014 Dec; 22(6):1010-8. PubMed ID: 25453521
[TBL] [Abstract][Full Text] [Related]
19. Treatment of non-small cell lung cancer with Yiqi Buxue prescriptions combined with adjuvant chemotherapy on the cancer therapy-related cardiovascular toxicity: A systematic review and meta-analysis.
Huang H; Liu B; Chen M; Qin Y; Li J; Li S; Xu X
J Ethnopharmacol; 2024 Apr; 323():117665. PubMed ID: 38159818
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of combining targeted therapy with pemetrexed or docetaxel as second-line treatment in patients with advanced non-small-cell lung cancer: a meta-analysis of 14 randomized controlled trials.
Li X; Wang H; Lin W; Xu Q
Curr Med Res Opin; 2014 Nov; 30(11):2295-304. PubMed ID: 24701984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
